Provided by Tiger Trade Technology Pte. Ltd.

INNOCARE

13.540
-0.150-1.10%
Volume:9.30M
Turnover:125.73M
Market Cap:23.93B
PE:30.48
High:13.820
Open:13.560
Low:13.230
Close:13.690
52wk High:20.180
52wk Low:9.650
Shares:1.77B
HK Float Shares:1.49B
Volume Ratio:1.23
T/O Rate:0.62%
Dividend:- -
Dividend Rate:- -
EPS(LYR):0.444
ROE:12.77%
ROA:4.28%
PB:2.67
PE(LYR):30.48
PS:7.36

Loading ...

Movement Alert|INNOCARE Falls 5.73% in Regular Trading, Biotech Sector Broadly Weak as National Insurance Negotiation Concludes

Market Focus
·
Sep 10

InnoCare Gets First Half of Remaining Stake Bought in Subsidiary

MT Newswires Live
·
Sep 08

UBS Flags Strong H1 Sales for Chinese Biotech Despite Regulatory Headwinds, Eyes Late-Year Catalysts

Stock News
·
Sep 07

Assessing the Value of InnoCare's ICP-488 in the Psoriasis Market

Deep News
·
Sep 04

Movement Alert|INNOCARE Rises 5.48% in Regular Trading, Multiple Institutions Issue Buy Ratings Amid Strong H1 Earnings

Market Focus
·
Sep 04

Party Time: Brokers Just Made Major Increases To Their InnoCare Pharma Limited (HKG:9969) Earnings Forecasts

Simply Wall St.
·
Aug 30

Goldman Sachs Lifts Innocare Price Target to HK$22.71 on Robust Orelabrutinib Sales

Stock News
·
Aug 28

InnoCare Pharma (SEHK:9969) Could Be 24% Undervalued Following Profit Turn

Simply Wall St.
·
Aug 28

InnoCare Pharma Limited Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year

Simply Wall St.
·
Aug 27

Market Sentiment Stabilizes as Sanctions Prove Largely Symbolic; Tech Benchmarks Surge on Potential Dovish Fed Signals

Stock News
·
Aug 25

InnoCare Pharma (SEHK:9969) Stock Jumps As Profit Arrives And Pipeline Risk Persists

Simply Wall St.
·
Aug 25

Movement Alert|INNOCARE Rises 5.08% in Regular Trading, H1 Earnings Show Return to Profitability with Revenue Up 55.5%

Market Focus
·
Aug 25

Press Release: InnoCare Reports 2026 Interim Results, Sustained Profitability and Key Milestones Achieved

Dow Jones
·
Aug 24

InnoCare Pharma Returns to Profit in H1

MT Newswires Live
·
Aug 24

InnoCare Pharma Swings to RMB 239.67 Million Profit on 55.5% Revenue Jump in H1 2026

Bulletin Express
·
Aug 24

China's InnoCare Pharma H1 Revenue Surges, Partly on Orelabrutinib Growth

Reuters
·
Aug 24

INNOCARE Posts Interim Results with Profit Turnaround on Adjusted Basis

Stock News
·
Aug 24

InnoCare Schedules 24 Aug 2026 Board Meeting to Review 1H 2026 Interim Results

Bulletin Express
·
Aug 11

Why InnoCare Pharma (SEHK:9969) Is Up 12.9% After Dual Breakthrough Therapy Wins in Cancer and Autoimmune Disease - And What's Next

Simply Wall St.
·
Aug 10

Movement Alert|INNOCARE Rises 5.17% in Regular Trading, Multiple Autoimmune Pipeline Clinical Milestones Driving Sustained Uptrend

Market Focus
·
Aug 10